ArticleVaccines2026

Longitudinal Assessment of an 800 µg Dose of HEBERSaVax in Non-Human Primates over Six Months.

Camila Canaán-Haden et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.